Takeda reports FY2026 Q1 results, solid revenue up 10.2% AER, and launch prep in Osaka, Japan; ORZEYFUL China approval accelerates pipeline
Takeda reports FY2026 Q1 results, solid revenue up 10.2% AER, and launch prep in Osaka, Japan; ORZEYFUL China approval accelerates pipeline Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track | Takeda Pharmaceuticals Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track | Takeda Pharmaceuticals Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track Solid first quarter performance broadly in line with guidance, underpinned by resilient demand across core in-line brands ...